A New Approach to Search for the Bioactive Conformation of Glucagon: Positional Cyclization Scanning
- 16 August 2001
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 44 (19) , 3109-3116
- https://doi.org/10.1021/jm010091q
Abstract
In search for the bioactive conformation of glucagon, “positional cyclization scanning” was used to determine secondary structures of glucagon required for maximal interaction with the glucagon receptor. Because glucagon is flexible in nature, its bioactive conformation is not known except for an amphiphilic helical conformation at the C-terminal region. To understand the conformational requirement for the N-terminal region that appears to be essential for signal transduction, a series of glucagon analogues conformationally constrained by disulfide or lactam bridges have been designed and synthesized. The conformational restrictions via disulfide bridges between cysteine i and cysteine i + 5, or lactam bridges between lysine i and glutamic acid i + 4, were applied to induce and stabilize certain corresponding secondary structures. The results from the binding assays showed that all the cyclic analogues with disulfide bridges bound to the receptor with significantly reduced binding affinities compared to their linear counterparts. On the contrary, glucagon analogues containing lactam bridges, in particular, c[Lys5, Glu9]glucagon amide (10) and c[Lys17, Glu21]glucagon amide (14), demonstrated more than 7-fold increased receptor binding affinities than native glucagon. These results suggest that the bioactive conformation of glucagon may adopt a helical conformation at the N-terminal region as well as the C-terminal region, which was not evident from earlier biophysical studies of glucagon.Keywords
This publication has 29 references indexed in Scilit:
- Structure−Function Studies on Positions 17, 18, and 21 Replacement Analogues of Glucagon: The Importance of Charged Residues and Salt Bridges in Glucagon Biological ActivityJournal of Medicinal Chemistry, 1998
- Structural relationships in the OmpR family of winged-helix transcription factorsJournal of Molecular Biology, 1997
- [des His1, des Phe6, Glu9]glucagon amide: A newly designed “pure” glucagon antagonistBioorganic & Medicinal Chemistry Letters, 1995
- STRUCTURE AND FUNCTION OF G PROTEIN-COUPLED RECEPTORSAnnual Review of Biochemistry, 1994
- Design of cyclic deltorphins and dermenkephalins with a disulfide bridge leads to analogs with high selectivity for .delta.-opioid receptorsJournal of Medicinal Chemistry, 1994
- CONSTRAINED PEPTIDES: MODELS OF BIOACTIVE PEPTIDES AND PROTEIN SUBSTRUCTURESAnnual Review of Biochemistry, 1992
- Conformational considerations in the design of a glucagon analog with increased receptor binding and adenylate cyclase potenciesJournal of the American Chemical Society, 1986
- Conformation of glucagon in a lipid-water interphase by 1H nuclear magnetic resonanceJournal of Molecular Biology, 1983
- A SURVEY OF X-RAY DIFFRACTION STUDIES OF ENZYME-OTHER MOLECULE INTERACTIONS AS POSSIBLE MODELS FOR RECEPTOR SITESAnnals of the New York Academy of Sciences, 1981
- Allylic Chlorides. IX. Preparation of cis and trans Crotyl ChlorideJournal of the American Chemical Society, 1950